Daily News
-
Innovative medical educators to share knowledge
Rheumatologic education is moving forward as quickly as rheumatologic treatment. With continuing funding from the Rheumatology Research Foundation, clinician educators develop a variety of new techniques to push the boundaries of medical education as they develop new techniques to collect, document, and analyze qualitative educational…
-
Caring for immunosuppressed patients can be complicated
Patients with autoimmune diseases who do not respond appropriately to treatment may be more complex than they first appear. They could also be immunodeficient.
-
Treatment for ANCA-associated vasculitis evolves
Treatment for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis has changed. What was once an acute, highly lethal disease has become a less lethal, more often chronic condition.
-
Mycophenolate trial results in scleroderma-related interstitial lung disease to be announced
A Monday afternoon session will answer whether it’s safer and more effective to use mycophenolate to treat interstitial lung disease in patients with scleroderma when compared with cyclophosphamide.
-
Rheumatology Research Foundation award helps educator establish reputation
Kenneth O’Rourke, MD, found his passion for educating at the beginning of his career at Wake Forest School of Medicine. As his classroom and clinical teaching career progressed, he quickly assumed administrative roles within the school’s medical student curriculum and also was named the rheumatology…
-
Biologics create vaccination confusion for clinicians
The success of biologics has created a conundrum for clinicians. Both of the diseases biologics are intended to treat and the biologics themselves can increase the risk for infection, heightening the need for appropriate vaccination practices.
-
New IPF treatments may work for interstitial lung disease
New approaches to the treatment of idiopathic pulmonary fibrosis (IPF) may affect the treatment of interstitial lung disease in the setting of systemic sclerosis and other rheumatologic conditions.
-
Pediatric clots more common than rheumatologists realize
The conventional wisdom that children are less likely to have thrombotic events than are adults is largely true — except in rheumatology.
-
Macrophage activation syndrome is a disorder in transition
Once recognized primarily in patients with juvenile idiopathic arthritis, macrophage activation syndrome (MAS) is now being seen as a disorder in transition for both children and adults in multiple clinical contexts: Patients with herpes virus infections, severe lupus flares, antiphospholipid syndrome, and maybe even patients…
-
Clinicians must know how to prove rheumatology’s value
Rheumatologists require no convincing that their care has great value, but payers are increasingly demanding evidence that rheumatologists add value.